Group items tagged Drugs - Cheap Generic ED drugs

Analytical Tools and Market Research On Lung Cancer - 1 views

Matilde Fernandes on 16 Jan 14

Chemotherapy drugs will experience generic erosion and three major chemotherapy drugs go off patent before 2012, comprising Aventis Taxotere (docetaxel), Bristol-Myers Squibbs Paraplatin (carboplatin) and Eli Lillys Gemzar (gemcitabine). The third-generation chemotherapeutic agents have expanded the therapeutic options in the treatment of advanced lung cancer. However, despite their contributions, science has reached a therapeutic plateau.

<div class="cArrow"> </div><div class="cContentInner">Chemotherapy drugs will experience generic erosion and three major chemotherapy drugs go off patent before 2012, comprising Aventis Taxotere (docetaxel), Bristol-Myers Squibbs Paraplatin (carboplatin) and Eli Lillys Gemzar (gemcitabine). The third-generation chemotherapeutic agents have expanded the therapeutic options in the treatment of advanced lung cancer. However, despite their contributions, science has reached a therapeutic plateau.</div>

...

Cancel

Market Research Reports on Peptides in Oncology - 1 views

www.listfree.org/tool-peptides-in-oncology.html

in industry research on peptides peptide drug development reports oncology treatment of cancer related

shared by Matilde Fernandes on 14 Jan 14 - No Cached

Matilde Fernandes on 14 Jan 14

A progress analysis on current and emerging drugs on the peptide drug development the reveals promising investment opportunities. Popular products included in the package are Cancer Peptides: From First-in-Class to Best-in-Class; and Peptides in Oncology Drug Pipeline Update 2013.

<div class="cArrow"> </div><div class="cContentInner">A progress analysis on current and emerging drugs on the peptide drug development the reveals promising investment opportunities. Popular products included in the package are Cancer Peptides: From First-in-Class to Best-in-Class; and Peptides in Oncology Drug Pipeline Update 2013.</div>

...

Cancel

Germany Drug Forecast and Market Analysis to 2022 - 0 views

www.researchongermany.com/d-market-analysis-to-2022.html

Profiles Reports Markets Market Industry Research Company supports Global rubber

shared by Matilde Fernandes on 13 Dec 13 - No Cached

Matilde Fernandes liked it

Matilde Fernandes on 13 Dec 13

The German chronic heart failure (CHF) therapeutics market was worth approximately USD 484.7 million in 2012, with a projected compound annual growth rate (CAGR) of 2.4%, to reach a total of USD 614.8 million in 2022. The launch of Novartis' novel combination drug, LCZ-696 in 2015 will mark the first entrance of a novel branded CHF drug in the past five years, boosting the overall market size considerably till 2022.

<div class="cArrow"> </div><div class="cContentInner">The German chronic heart failure (CHF) therapeutics market was worth approximately USD 484.7 million in 2012, with a projected compound annual growth rate (CAGR) of 2.4%, to reach a total of USD 614.8 million in 2022. The launch of Novartis' novel combination drug, LCZ-696 in 2015 will mark the first entrance of a novel branded CHF drug in the past five years, boosting the overall market size considerably till 2022.</div>

...

Cancel

Buy Fildena 100, 50, 25 and Fildena XXX Online - 3 views

cheapgenericeddrug.com/...fildena

Generic ED Drugs Filagra Fildena Tadalista Filitra Order Online

shared by Matilde Fernandes on 14 Nov 14 - No Cached

Matilde Fernandes liked it

Matilde Fernandes on 14 Nov 14

Fildena works outstanding by curing impotence in men. The drug works outstanding by fighting sensual disabilities from the core. Impotence in men has become a common disorder; the lost sexual stamina can be easily recovered with the help of this drug.

<div class="cArrow"> </div><div class="cContentInner">Fildena works outstanding by curing impotence in men. The drug works outstanding by fighting sensual disabilities from the core. Impotence in men has become a common disorder; the lost sexual stamina can be easily recovered with the help of this drug.</div>

...

Cancel

Report- Global Retinoblastoma Drugs Industry 2015 Market Research Report - 0 views

naincy on 29 Oct 15

2015 Global Retinoblastoma Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Retinoblastoma Drugs industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).

<div class="cArrow"> </div><div class="cContentInner">2015 Global Retinoblastoma Drugs Industry Report is a professional and in-depth research report on the world's major regional market conditions of the Retinoblastoma Drugs industry, focusing on the main regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China).</div>

...

Cancel

Market Research on Analytical Tool for Apoptosis in Oncology - 1 views

Matilde Fernandes on 17 Jan 14

The tool on apoptosis in oncology also assists in analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future.

<div class="cArrow"> </div><div class="cContentInner">The tool on apoptosis in oncology also assists in analyzing the vast amount of strategic possibilities that have emerged in apoptotic drug development for the treatment of cancer. It is at the same time a map of the research and development, a history of the achievements up to date, and a guide pointing out the directions of the future.</div>

...

Cancel

Market research report on antibodies and peptides in oncology - 0 views

www.listfree.org/-and-peptides-in-oncology.html

Antibodies and Peptides in Oncology market on Research report business development the antibody peptide drug Cancer

shared by Matilde Fernandes on 14 Jan 14 - No Cached

Matilde Fernandes on 14 Jan 14

Analytical tools to analyses antibodies and peptides in oncology lead to analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and peptide cancer drug competitive landscape. A progress analysis on current and emerging drugs for cancer antibodies in oncology lays down a comprehensive framework for further analysis of the field.

<div class="cArrow"> </div><div class="cContentInner">Analytical tools to analyses antibodies and peptides in oncology lead to analyzing the vast amount of strategic possibilities that have emerged in R&D and business development in the antibody and peptide cancer drug competitive landscape. A progress analysis on current and emerging drugs for cancer antibodies in oncology lays down a comprehensive framework for further analysis of the field.</div>

...

Cancel

Research On PI3Ks and BTK Inhibitors market drivers of M&A in 2013-2016 - 2 views

www.listfree.org/-pi3ks-and-btk-inhibitors.html

Drivers of M&A for PI3Ks and BTK Inhibitors Research Market Industry Global Reports Profiles Markets Company

shared by Matilde Fernandes on 15 Jan 14 - No Cached

Matilde Fernandes liked it

Matilde Fernandes on 15 Jan 14

Unmet needs in hematologic malignancies calls for companies focusing on PI3Ks and BTK inhibitors to offer better treatment options. Around USD 10 bn has already been invested in licensing and acquisition of PI3K and other kinase inhibitors since the last five years. Targeting kinases have been on the agenda of most drug developers as they hold the key path to signaling, development and growth of the cell. Large global pharma are constantly on the hunt for drugs with label expansion potential, longevity and blockbuster potential.

<div class="cArrow"> </div><div class="cContentInner">Unmet needs in hematologic malignancies calls for companies focusing on PI3Ks and BTK inhibitors to offer better treatment options. Around USD 10 bn has already been invested in licensing and acquisition of PI3K and other kinase inhibitors since the last five years. Targeting kinases have been on the agenda of most drug developers as they hold the key path to signaling, development and growth of the cell. Large global pharma are constantly on the hunt for drugs with label expansion potential, longevity and blockbuster potential.</div>

...

Cancel

Therapeutic Class Report Overview of Hepatitis C Virus Infection - 2 views

Matilde Fernandes on 15 Jan 14

The launch of Protease Inhibitors (PIs) accelerated the pace of innovation and impressive Sustained Virologic Response (SVR) rates by oral IFN free drug combinations. Freedom from IFN, treating all genotypes and vaccines could bring a sea of change in the HCV therapy class area in the future. Roche set the trend with the acquisition of Anadys for total of USD 230 mn followed by GILD buying VRUS for USD 11 bn, Bristol-Myers Squibb (BMY) acquiring Inhibitex for USD 2.5 bn, VRTX acquiring Virochem in 2009 for USD 375 mn, In-licensed Alios VX-135 in 2012 for total of USD 775 mn and Abbott in-licensed Enantas ABT-450 for total of USD 310 mn.

<div class="cArrow"> </div><div class="cContentInner">The launch of Protease Inhibitors (PIs) accelerated the pace of innovation and impressive Sustained Virologic Response (SVR) rates by oral IFN free drug combinations. Freedom from IFN, treating all genotypes and vaccines could bring a sea of change in the HCV therapy class area in the future. Roche set the trend with the acquisition of Anadys for total of USD 230 mn followed by GILD buying VRUS for USD 11 bn, Bristol-Myers Squibb (BMY) acquiring Inhibitex for USD 2.5 bn, VRTX acquiring Virochem in 2009 for USD 375 mn, In-licensed Alios VX-135 in 2012 for total of USD 775 mn and Abbott in-licensed Enantas ABT-450 for total of USD 310 mn.</div>

...

Cancel

Pharmaceutical Market Outlook in South Korea 2013 - 2 views

Matilde Fernandes on 06 Mar 14

The South Korean pharmaceutical industry is highly fragmented, with almost all the domestic pharmaceutical companies having a strong portfolio of generic products rather than expensive, branded drugs. An increase in insurance coverage, an ageing population and favorable government initiatives are expected to drive future growth in the pharmaceutical industry in South Korea. Improved intellectual property rights, changing demographics and government support have contributed towards making the South Korean pharmaceutical industry attractive for MNCs.

<div class="cArrow"> </div><div class="cContentInner">The South Korean pharmaceutical industry is highly fragmented, with almost all the domestic pharmaceutical companies having a strong portfolio of generic products rather than expensive, branded drugs. An increase in insurance coverage, an ageing population and favorable government initiatives are expected to drive future growth in the pharmaceutical industry in South Korea. Improved intellectual property rights, changing demographics and government support have contributed towards making the South Korean pharmaceutical industry attractive for MNCs.</div>

...

Cancel

United States Drug Forecast and Market Analysis Research Report - 0 views

research-report.ucoz.com/...2013-12-19-15

Profiles Reports Markets Industry Global rubber supports Market Research Company

shared by Matilde Fernandes on 20 Dec 13 - No Cached

Matilde Fernandes on 20 Dec 13

The non-existence of effective vaccine against HCV leads the healthcare market in United States to be driven by therapeutics. Vertexs Incivek was amongst the first DAA HCV therapies launched in the US and is the current market leader. Inciveks improved efficacy over the previous standard of care in the treatment of the most prevalent HCV genotype in the US, HCV GT1, which enabled the drug to quickly capture the market. Adverse events associated with Incivek therapy, such as life-threatening skin reactions, and the slow-progressing nature of HCV, has resulted in many patients deciding to forego treatment in order to wait for the launch of a more-tolerable HCV regimen.

<div class="cArrow"> </div><div class="cContentInner">The non-existence of effective vaccine against HCV leads the healthcare market in United States to be driven by therapeutics. Vertexs Incivek was amongst the first DAA HCV therapies launched in the US and is the current market leader. Inciveks improved efficacy over the previous standard of care in the treatment of the most prevalent HCV genotype in the US, HCV GT1, which enabled the drug to quickly capture the market. Adverse events associated with Incivek therapy, such as life-threatening skin reactions, and the slow-progressing nature of HCV, has resulted in many patients deciding to forego treatment in order to wait for the launch of a more-tolerable HCV regimen.</div>

...

Cancel

Global Fatty Liver Disease Trials Reviews - 1 views

www.marketpressrelease.com/Review-H2-2013-1395660250.html

Fatty Liver Global Review 2013 clinical trial scenario elemental information trials on drugs for treating preliminary coverage disease

shared by Matilde Fernandes on 25 Mar 14 - No Cached

Matilde Fernandes liked it

Matilde Fernandes on 25 Mar 14

Elemental information and data relating to the clinical trials on fatty liver disease including an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe offers a perspective on the fatty liver disease clinical trial scenario. Disease clinical trials by their phase, trial status, prominence of the sponsors pertaining to the number of trials for the key drugs for treating fatty liver disease hints at the dynamics of a particular indication in a condensed manner in addition to the commercial landscape of the major universities, institutes, hospitals or companies.

<div class="cArrow"> </div><div class="cContentInner">Elemental information and data relating to the clinical trials on fatty liver disease including an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe offers a perspective on the fatty liver disease clinical trial scenario. Disease clinical trials by their phase, trial status, prominence of the sponsors pertaining to the number of trials for the key drugs for treating fatty liver disease hints at the dynamics of a particular indication in a condensed manner in addition to the commercial landscape of the major universities, institutes, hospitals or companies.</div>

...

Cancel

Uveitis Opportunity Analysis and Market Research Reports - 1 views

shared by Matilde Fernandes on 26 Mar 14 - No Cached

Matilde Fernandes liked it

Matilde Fernandes on 26 Mar 14

With conventional corticosteroid treatment being effective in only 50-60% of patients, development of new treatment options is necessary to cover the unmet needs of the uveitis market. The market is currently dominated by corticosteroid treatment options and off-label immunosuppressive and biologic drugs. Although anterior uveitis patients constitute the major share of patients, except one, all the new treatments in late stage clinical development target the intermediate, posterior and pan uveitis patient segment. Drugs capable of permanently inhibiting ocular inflammation as well as offering an improved safety profile will have a significant impact on the uveitis market.

<div class="cArrow"> </div><div class="cContentInner">With conventional corticosteroid treatment being effective in only 50-60% of patients, development of new treatment options is necessary to cover the unmet needs of the uveitis market. The market is currently dominated by corticosteroid treatment options and off-label immunosuppressive and biologic drugs. Although anterior uveitis patients constitute the major share of patients, except one, all the new treatments in late stage clinical development target the intermediate, posterior and pan uveitis patient segment. Drugs capable of permanently inhibiting ocular inflammation as well as offering an improved safety profile will have a significant impact on the uveitis market.</div>

...

Cancel

Malaria Market Pipeline Review and Research Reports - 1 views

www.researchonglobalmarkets.com/a-pipeline-review-h1-2014.html

Malaria Research and Treatment Therapeutic Products Review Drugs

shared by Matilde Fernandes on 05 Jun 14 - No Cached

Matilde Fernandes liked it

Matilde Fernandes on 05 Jun 14

Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company.

<div class="cArrow"> </div><div class="cContentInner">Global Markets Directs report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Directs proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company.</div>

...

Cancel

Generic ED Drugs, Filagra, Fildena, Tadalista, Filitra, Order Online - 1 views

www.cheapgenericeddrug.com

Generic ED Drugs Filagra Fildena Tadalista Filitra Order Online

shared by Matilde Fernandes on 14 Nov 14 - No Cached

Matilde Fernandes liked it

Matilde Fernandes on 14 Nov 14

Anyone who is facing ED problems can get solution of their problem through this ED medication. This is cheap as well as really effective on your problem.

<div class="cArrow"> </div><div class="cContentInner">Anyone who is facing ED problems can get solution of their problem through this ED medication. This is cheap as well as really effective on your problem.</div>

...

Cancel

Global Clinical Trials Review on Abdominal Obesity - 3 views

www.researchonglobalmarkets.com/cal-trials-review-h1-2014.html

Abdominal Obesity Trials Review Global Clinical Weight Loss

shared by Matilde Fernandes on 09 Jun 14 - No Cached

Matilde Fernandes liked it

Matilde Fernandes on 09 Jun 14

This report includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Abdominal Obesity.

<div class="cArrow"> </div><div class="cContentInner">This report includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Abdominal Obesity.</div>

...

Cancel
anastacia3344 on 27 Jun 22

Interesting info. What other meds can be taken?

<div class="cArrow"> </div><div class="cContentInner">Interesting info. What other meds can be taken?</div>

...

Cancel
rachel999 on 27 Jun 22

As far as I know, Xenical (Orlistat) promotes weight loss by decreasing the amount of dietary fat absorbed in your intestines. You can find out more about it on the Canada Drugs site https://www.canadadrugsdirect.com/. It has to be noted, that this medication should only be used under the supervision of a trained healthcare professional.

<div class="cArrow"> </div><div class="cContentInner">As far as I know, Xenical (Orlistat) promotes weight loss by decreasing the amount of dietary fat absorbed in your intestines. You can find out more about it on the Canada Drugs site <a href="https://www.canadadrugsdirect.com/" rel="nofollow" target="_blank">https://www.canadadrugsdirect.com/</a>. It has to be noted, that this medication should only be used under the supervision of a trained healthcare professional.</div>

...

Cancel

Analytical Tool for Leukemia Business Development - 1 views

Matilde Fernandes on 16 Jan 14

Analysis of leukemia business development enables tracking cutting edge companies, therapies and new technologies. Analysis of key areas of pharmaceutical R&D helps identify emerging leukemia products. The tool is designed in a way to assist in finding right partners, optimizing licensing deals and choosing projects that give the best competitive advantage.

<div class="cArrow"> </div><div class="cContentInner">Analysis of leukemia business development enables tracking cutting edge companies, therapies and new technologies. Analysis of key areas of pharmaceutical R&D helps identify emerging leukemia products. The tool is designed in a way to assist in finding right partners, optimizing licensing deals and choosing projects that give the best competitive advantage.</div>

...

Cancel

Global Research Report on Parkinson's Disease Market - 1 views

industry-research-report.blogspot.in/...nsons-disease-market-2012.html

Global Parkinson's Disease market weak pipeline landscape in-depth analysis trends opportunities size challenges to growth

shared by Matilde Fernandes on 24 Jan 14 - No Cached

Matilde Fernandes on 24 Jan 14

One of the main drivers propelling the growth of the market for drugs used to treat patients with Parkinson's disease is the steadily growing aging population worldwide. This is because the number of patients suffering from Parkinson's disease is increasing owing to the rise in aging population both in the developing as well as developed nations. One of the major challenges to market growth is the weak pipeline landscape. Most products in the pipeline lack molecules that can potentially achieve blockbuster status in the near future.

<div class="cArrow"> </div><div class="cContentInner">One of the main drivers propelling the growth of the market for drugs used to treat patients with Parkinson's disease is the steadily growing aging population worldwide. This is because the number of patients suffering from Parkinson's disease is increasing owing to the rise in aging population both in the developing as well as developed nations. One of the major challenges to market growth is the weak pipeline landscape. Most products in the pipeline lack molecules that can potentially achieve blockbuster status in the near future.</div>

...

Cancel

India Drug Forecast and Market Analysis for Dry Eye Syndrome - 0 views

research-report.ucoz.com/...2013-12-23-17

Global Company Research Markets Profiles Industry Reports supports Market rubber

shared by Matilde Fernandes on 24 Dec 13 - No Cached

Matilde Fernandes on 24 Dec 13

Dry eye syndrome (DES), or keratoconjunctivitis sicca, is a multifactorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. DES, which is often referred to simply as dry eye, is the most prevalent form of ocular discomfort and irritation. The most common symptoms of DES are ocular irritation and discomfort, foreign body sensation, fatigue, and visual disturbances, which interfere with daily activities. In the elderly population, it is the most common reason for seeking eye care, and this is expected to increase exponentially with an aging demographic.

<div class="cArrow"> </div><div class="cContentInner">Dry eye syndrome (DES), or keratoconjunctivitis sicca, is a multifactorial disease of the eye caused by dryness, decreased tear production, or increased tear film evaporation. DES, which is often referred to simply as dry eye, is the most prevalent form of ocular discomfort and irritation. The most common symptoms of DES are ocular irritation and discomfort, foreign body sensation, fatigue, and visual disturbances, which interfere with daily activities. In the elderly population, it is the most common reason for seeking eye care, and this is expected to increase exponentially with an aging demographic.</div>

...

Cancel

Parkinsons disease review that key players are focusing - 2 views

new.pitchengine.com/...9b-7f3d-496e-aa3b-54ad30a44d05

Parkinson's Disease Research Report Parkinson Review News

shared by Matilde Fernandes on 08 May 14 - No Cached

Matilde Fernandes liked it

Matilde Fernandes on 08 May 14

This report provides comprehensive information on the therapeutic development for Parkinson's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.

<div class="cArrow"> </div><div class="cContentInner">This report provides comprehensive information on the therapeutic development for Parkinson's Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases.</div>

...

Cancel

Group items tagged

Analytical Tools and Market Research On Lung Cancer - 1 views

Market Research Reports on Peptides in Oncology - 1 views

Germany Drug Forecast and Market Analysis to 2022 - 0 views

Buy Fildena 100, 50, 25 and Fildena XXX Online - 3 views

Report- Global Retinoblastoma Drugs Industry 2015 Market Research Report - 0 views

Market Research on Analytical Tool for Apoptosis in Oncology - 1 views

Market research report on antibodies and peptides in oncology - 0 views

Research On PI3Ks and BTK Inhibitors market drivers of M&A in 2013-2016 - 2 views

Therapeutic Class Report Overview of Hepatitis C Virus Infection - 2 views

Pharmaceutical Market Outlook in South Korea 2013 - 2 views

United States Drug Forecast and Market Analysis Research Report - 0 views

Global Fatty Liver Disease Trials Reviews - 1 views

Uveitis Opportunity Analysis and Market Research Reports - 1 views

Malaria Market Pipeline Review and Research Reports - 1 views

Generic ED Drugs, Filagra, Fildena, Tadalista, Filitra, Order Online - 1 views

Global Clinical Trials Review on Abdominal Obesity - 3 views

Analytical Tool for Leukemia Business Development - 1 views

Global Research Report on Parkinson's Disease Market - 1 views

India Drug Forecast and Market Analysis for Dry Eye Syndrome - 0 views

Parkinsons disease review that key players are focusing - 2 views

Related searches